Literature DB >> 11046084

Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism.

G A Figtree1, C M Webb, P Collins.   

Abstract

In epidemiological studies tamoxifen has been associated with a reduction in the incidence of fatal myocardial infarction in women. However, the effects of tamoxifen on coronary artery reactivity are unknown. We hypothesized that tamoxifen would relax precontracted isolated rabbit coronary arteries. Rings of coronary artery from adult male and nonpregnant female New Zealand White rabbits were suspended in organ baths containing Krebs' solution; isometric tension was measured. Tamoxifen (0.1-100 microM) induced significant endothelium-dependent relaxation in precontracted rabbit coronary arteries. This relaxation was inhibited by N(omega)-nitro-L-arginine methyl ester and the estrogen receptor antagonist ICI 182,780. There was no significant effect on calcium concentration-dependent contraction curves. These data suggest that tamoxifen has beneficial effects on coronary reactivity that could, at least in part, account for the reduction in risk of fatal myocardial infarction in women taking tamoxifen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11046084

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Estrogen dependence of the renal vasodilatory effect of nicotine in rats: role of α7 nicotinic cholinergic receptor/eNOS signaling.

Authors:  Mahmoud M el-Mas; Sahar M el-Gowilly; Eman Y Gohar; Abdel-Rheem M Ghazal; Abdel A Abdel-Rahman
Journal:  Life Sci       Date:  2010-11-16       Impact factor: 5.037

2.  Tamoxifen dilates porcine coronary arteries: roles for nitric oxide and ouabain-sensitive mechanisms.

Authors:  H S Leung; L M Yung; F P Leung; X Yao; Z Y Chen; W H Ko; I Laher; Y Huang
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

Review 3.  Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.

Authors:  Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

4.  Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.

Authors:  Graciliano R A do Nascimento; Yaskara V R Barros; Amanda K Wells; Raouf A Khalil
Journal:  Curr Hypertens Rev       Date:  2009-11

5.  Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780.

Authors:  Matthias R Meyer; Oliver Baretella; Eric R Prossnitz; Matthias Barton
Journal:  Pharmacology       Date:  2010-07-17       Impact factor: 2.547

6.  Meta-analysis of vascular and neoplastic events associated with tamoxifen.

Authors:  R Scott Braithwaite; Rowan T Chlebowski; Joseph Lau; Suzanne George; Rachel Hess; Nananda F Col
Journal:  J Gen Intern Med       Date:  2003-11       Impact factor: 5.128

7.  Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry.

Authors:  Fernando P Filgueira; Núbia S Lobato; Denise L Nascimento; Graziela S Ceravolo; Fernanda R C Giachini; Victor V Lima; Ana Paula Dantas; Zuleica B Fortes; R Clinton Webb; Rita C Tostes; Maria Helena C Carvalho
Journal:  Steroids       Date:  2018-11-17       Impact factor: 2.668

Review 8.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Effects of tamoxifen on myocardial ischemia-reperfusion injury model in ovariectomized rats.

Authors:  Rauf Onur Ek; Yuksel Yildiz; Serpil Cecen; Cigdem Yenisey; Tulay Kavak
Journal:  Mol Cell Biochem       Date:  2007-11-03       Impact factor: 3.396

Review 10.  G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease.

Authors:  Guichun Han; Richard E White
Journal:  World J Cardiol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.